HGD gene
The HGD gene provides instructions for making an enzyme that breaks down specific amino acids, and mutations in this gene cause the metabolic disorder alkaptonuria.
Normal Function
The HGD gene provides instructions for making an enzyme called homogentisate 1,2-dioxygenase, which is active mainly in the liver and kidneys. This enzyme participates in a multi-step process that breaks down two protein building blocks (amino acids), phenylalanine and tyrosine. These amino acids also play a role in making certain brain chemicals (neurotransmitters), hormones, and pigments.
Homogentisate 1,2-dioxygenase is responsible for a specific step in the breakdown of phenylalanine and tyrosine. It adds two oxygen atoms to homogentisic acid, converting it to another molecule called maleylacetoacetate. Other enzymes then break down maleylacetoacetate into smaller molecules that are used for energy or to make other products.
Health Conditions Related to Genetic Changes
Alkaptonuria
Hundreds of variants in the HGD gene have been found to cause alkaptonuria. This condition is characterized by:
- Arthritis
- Kidney stones
- Areas of dark pigmentation
- Dark urine
Most of the HGD gene variants change single amino acids in the homogentisate 1,2-dioxygenase enzyme, severely reducing its function. Without a fully functional enzyme, phenylalanine and tyrosine are not broken down properly, and homogentisic acid builds up in the body.
Excess homogentisic acid settles in connective tissues and forms a substance called ochronotic pigment, which causes cartilage and skin to darken. Over time, this pigment can build up and harden (calcify), leading to health problems. Excess homogentisic acid is also excreted in urine, which makes urine turn dark when it is exposed to air.
